Epileptic seizure associated with intracerebroventricular and intrathecal morphine bolus

Pain

Volumn 75, Issue 2-3, 1998, Pages 383-387

  Kronenberg, Martina F ^a   Laimer, Inge ^a   Rifici, Carmela ^b   Saltuari, Leopold ^a   Bramanti, Placido ^b   Moriggl, Ursula ^a   Norer, Burghard ^a   Kofler, Alexandra ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Intrathecal; Intraventricular; Morphine; Pain; Seizure

Indexed keywords

MORPHINE;

ADULT; ARTICLE; BOLUS INJECTION; CANCER PAIN; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MINIPUMP; PRIORITY JOURNAL; SEIZURE;

ADULT; AGED; ANALGESICS, OPIOID; CARCINOMA, SQUAMOUS CELL; EPILEPSY; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MORPHINE; PAIN, INTRACTABLE; URINARY BLADDER NEOPLASMS;

EID: 0031947706     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00173-5     Document Type: Article

References (38)

1. Borgeat A., Biollaz J., Depierraz B., Neff R. Grand mal seizure after extradural morphine analgesia. Br. J. Anaesth. 60:1988;733-735.
2. Brazenor G.A. Long term intrathecal administration of morphine: a comparison of bolus injection via reservoir with continuous infusion by implanted pump. Neurosurgery. 21:1987;484-491.
3. de Armendi A.J., Fahey M., Ryan J.F. Morphine-induced myoclonic movements in a pediatric pain patient. Anesth. Analg. 77:1993;191-192.
4. Dennis G.C., DeWitty R.L. Long-term intraventricular infusion of morphine for intractable pain in cancer of the head and neck. Neurosurgery. 26:1990;404-408.
5. Follett K.A., Hitchon P.W., Piper J., Kumar V., Clamon G., Jones M.P. Response of intractable pain to continuous intrathecal morphine: a retrospective study. Pain. 49:1992;21-25.
6. Foote F., Gale K. Morphine potentiates seizures induced by GABA antagonists and attenuates seizures induced by electroshock in the rat. Eur. J. Pharmacol. 95:1983;259-264.
7. Frenk H., Liban A., Balamuth R., Urca G. Opiate and non-opiate aspects of morphine induced seizures. Brain Res. 253:1982;253-261.
8. Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res. 287:1983;197-210.
9. Glare P.A., Walsh T.D., Pippenger C.E. Normorphine, a neurotoxic metabolite? Lancet. 335:1990;725-726.
10. Gregory R.E., Grossman S., Sheidler V.R. Grand mal seizures associated with high-dose intravenous morphine infusions: incidence and possible etiology. Pain. 51:1992;255-259.
11. Groudine S.B., Cresanti-Daknis C., Lumb P.D. Successful treatment of a massive intrathecal morphine overdose. Anesthesiology. 82:1995;292-295.
12. Ikonomidou-Turski C., Cavalheiro E.A., Turski W.A., Bortolotto Z.A., Turski L. Convulsant action of morphine, [D-Ala2, D-Leu5]-enkephalin and naloxone in the rat amygdala: electroencephalographic, morphological and behavioural sequelae. Neuroscience. 20:1987;671-686.
13. Jacobson L. Intrathecal and extradural narcotics. Adv. Pain Res. Ther. 7:1984;199-236.
14. Karavelis A., Foroglou G., Selviaridis P., Fountzilas G. Intraventricular administration of morphine for control of intractable cancer pain in 90 patients. Neurosurgery. 39:1996;57-62.
15. Kearse L.A., Koski G., Husain M.V., Philbin D.M., McPeck K. Epileptiform activity during opioid anesthesia. Electroenceph. clin. Neurol. 87:1993;374-379.
16. Labella F.S., Pinsky C., Havlicek V. Morphine derivates with diminished opiate receptor potency show enhanced central excitatory activity. Brain Res. 174:1979;263-271.
17. Leavens M.E., Hill S. Jr., Cech D.A., Weyland J.B., Weston J.S. Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J. Neurosurg. 56:1982;241-245.
18. Lobato R.D., Madrid J.L., Fatela L.V., Rivas J.J., Reig E., Lamas E. Intraventricular morphine for control of pain in terminal cancer patients. J. Neurosurg. 59:1983;627-633.
19. Lutfy K., Woodward R.M., Keana J.F.W., Weber E. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists - MK-801 and Acea-1011. Eur. J. Pharmacol. 252:1994;261-266.
20. Mansour A., Valenstein E.S. Morphine responsiveness and seizure proneness. Exp. Neurol. 85:1984;346-357.
21. Meisel S.B., Welford P.K. Seizures associated with high-dose intravenous morphine containing sodium bisulfite preservative. Ann. Pharmacother. 26:1992;1515-1517.
22. Onofrio B.M., Yaksh T.L. Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J. Neurosurg. 72:1990;200-209.
23. Parkinson S.K., Bailey S.L., Little W.L., Mueller J.B. Myoclonic seizure activity with chronic high-dose spinal opioid administration. Anesthesiology. 72:1990;743-745.
24. Penn R.D., Paice J.A. Chronic intrathecal morphine for intractable pain. J. Neurosurg. 67:1987;182-186.
25. Reigel C.E., Jobe P.C., Dailey J.W., Stewart J.J. Responsiveness of genetically epilepsy-prone rats to intracerebroventricular morphine-induced convulsions. Life Sci. 42:1988;1743-1749.
26. Sauter K., Kaufman H.H., Bloomfield S.M., Cline S., Banks D. Treatment of high-dose intrathecal morphine overdose: case report. J. Neurosurg. 81:1994;143-146.
27. Shetter A.G., Hadley M.N., Wilkinson E. Administration of intraspinal morphine sulfate for the treatment of intractable cancer pain. Neurosurgery. 18:1986;740-747.
28. Sjogren P., Jonsson T., Jensen N.-H., Drenck N.-E., Jensen T.S. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain. 55:1993;93-97.
29. Snead O.C. Opiate-induced seizures: a study of mu and delta specific mechanisms. Exp. Neurol. 93:1986;348-358.
30. Tortella F.C., Robles L.E., Holaday J.W., Cowan A. A selective role for δ-receptors in the regulation of opioid-induced changes in seizure threshold. Life Sci. 33(Suppl. 1):1983;603-606.
31. Urca G., Frenk H. Pro- and anticonvulsant action of morphine in rats. Pharmacol. Biochem. Behav. 13:1980;343-347.
32. Van Dongen R.T.M., Crul B.J.P., De Bock M. Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases. Pain. 55:1993;119-123.
33. Wagemans M.F.M., Bakker E.N., Zuurmond W.W.A., Spoelder E.M., Van Loenen A.C., De Lange J.J. Intrathecal administration of high-dose morphine solutions decreases the pH of cerebrospinal fluid. Pain. 61:1995;55-59.
34. Wang J.K., Nauss L.A., Thomas J.E. Pain relief by intrathecally applied morphine in man. Anesthesiology. 50:1979;149-151.
35. Werz M.A., Macdonald R.L. Opiate alkaloids antagonize postsynaptic glycine and GABA responses: correlation with convulsant action. Brain Res. 236:1982;107-119.
36. Winkelmüller M., Winkelmüller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J. Neurosurg. 85:1996;458-467.
37. Yaksh T.L., Onofrio B.M. Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians. Pain. 31:1987;211-223.
38. Zieglgänsberger W., French E.D., Siggins G.R., Bloom F.E. Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science. 205:1979;415-417.